X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/oncovent-a-subsidiary-of-hepalink-enters-into-a-license-and-distribution-agreement-with-orient-europharma-for-the-immunotherapeutic-candidate-oregovomab-301783039.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215693
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205932